ES2013970A6 - Procedimiento para la obtencion de formas farmaceuticas de liberacion sostenida yno controlada de flutamida. - Google Patents

Procedimiento para la obtencion de formas farmaceuticas de liberacion sostenida yno controlada de flutamida.

Info

Publication number
ES2013970A6
ES2013970A6 ES8902721A ES8902721A ES2013970A6 ES 2013970 A6 ES2013970 A6 ES 2013970A6 ES 8902721 A ES8902721 A ES 8902721A ES 8902721 A ES8902721 A ES 8902721A ES 2013970 A6 ES2013970 A6 ES 2013970A6
Authority
ES
Spain
Prior art keywords
flutamide
continuous
controlled release
formulations
bioavailability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8902721A
Other languages
English (en)
Spanish (es)
Inventor
Luis Prizont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lboratorio Datsa S A
Original Assignee
Lboratorio Datsa S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lboratorio Datsa S A filed Critical Lboratorio Datsa S A
Publication of ES2013970A6 publication Critical patent/ES2013970A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES8902721A 1989-06-19 1989-08-01 Procedimiento para la obtencion de formas farmaceuticas de liberacion sostenida yno controlada de flutamida. Expired - Lifetime ES2013970A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8914039A GB2222947A (en) 1989-06-19 1989-06-19 Continuous/controlled release flutamide formulations

Publications (1)

Publication Number Publication Date
ES2013970A6 true ES2013970A6 (es) 1990-06-01

Family

ID=10658674

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8902721A Expired - Lifetime ES2013970A6 (es) 1989-06-19 1989-08-01 Procedimiento para la obtencion de formas farmaceuticas de liberacion sostenida yno controlada de flutamida.

Country Status (5)

Country Link
DE (1) DE4019512A1 (it)
ES (1) ES2013970A6 (it)
FR (1) FR2648349A1 (it)
GB (1) GB2222947A (it)
IT (1) IT1240954B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162117A (en) * 1991-11-22 1992-11-10 Schering Corporation Controlled release flutamide composition
CN103908435B (zh) * 2013-01-04 2018-02-16 江苏天士力帝益药业有限公司 一种氟他胺缓释制剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139638A (en) * 1976-09-23 1979-02-13 Schering Corporation Methods for the treatment of hirsutism
US4474813A (en) * 1980-10-24 1984-10-02 Schering Corporation Pharmaceutical preparations comprising flutamide

Also Published As

Publication number Publication date
IT9067447A1 (it) 1991-12-19
GB8914039D0 (en) 1989-08-09
IT9067447A0 (it) 1990-06-19
GB2222947A (en) 1990-03-28
IT1240954B (it) 1993-12-27
DE4019512A1 (de) 1991-01-17
FR2648349A1 (fr) 1990-12-21

Similar Documents

Publication Publication Date Title
Brade et al. Ifosfamide-pharmacology, safety and therapeutic potential
NO884259L (no) Doseringsanordning til behandling av kardiovaskulaere sykdommer.
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
BG105856A (bg) Използване на хидроксиматерезинол за предотвратяване на рак
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
SE8204581L (sv) Farmaceutiska excipienter
IT1104643B (it) Sistema terapeutico in forma di cerotto o simile per la somministrazione di clonidina per via transdermica e procedimento per la sua preparazione
Carson et al. Colonic ulceration and bleeding during diclofenac therapy
DK1098643T3 (da) Phenylacetylglutamin, phenylacetylisoglutamin og/eller phenylacetat til behandling af neoplastiske sygdomme
PT81091A (en) Substained release tablets and method for preparation thereof
HK60192A (en) Drug particles having constant release
JPS5218813A (en) Plasters for the relief of cutaneous diseases
ES2013970A6 (es) Procedimiento para la obtencion de formas farmaceuticas de liberacion sostenida yno controlada de flutamida.
JPS52128205A (en) Prophylactic and therapeutic drugs for cerebro-vascular contraction
JPS523023A (en) Preparation of amino acid ester of organopolysiloxane
JPS525738A (en) Process for racemization of optically active 2,2-dimethyl-3-(2,2-dichl orovinyl)-cyclopropanecarboxylic acid and its derivatives
JPS53149940A (en) Novel benzyl alcohol derivatives and their preparation
JPS5785318A (en) Hydrophilic medical material
JPS53130421A (en) Remedy for uterine cancer and its preparation
JPS53129285A (en) Preparation of resin
AIRAPETYAN PRINCIPLES FOR THE LOCATION OF MEASURES OF EROSION CONTROL IN ARMENIAN HIGHLANDS(IN AMERICAN)
Higuchi et al. Effect of age on antipyrine metabolism in patients with gastric cancer
JPS5268399A (en) Liquid crystal display unit
JPS57193413A (en) Medicament for alleviating hypercalcemia
JPS5241207A (en) Extraction of carcinostatic substances from shepherd's purse